AGE
$1.66
Agex Therapeutics
($.12)
(6.74%)
AGE
Earnings Whisper ®
N/A
Consensus:  $0.00
Revenue:  N/A
Friday
Nov 13
After the close
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when AGE reports earnings?
Beat
Meet
Miss

Where is AGE's stock price going from here?
Up
Flat
Down
Stock chart of AGE
Analysts
Summary of analysts' recommendations for AGE
Score
Grade
Pivots
Resistance
$2.01
$1.92
$1.79

$1.70

Support
$1.57
$1.48
$1.35
Tweet
Growth
Description
AgeX Therapeutics Inc. is involved in the development and commercialization of novel therapeutics targeting human aging. The company's proprietary technology consists of PureStem(R) and Tissue Regeneration(TM). Its product pipeline includes AGEX-VASC1, AGEX-BAT1, AGEX-iTR1547 and Renelon(TM). AgeX Therapeutics Inc. is based in Alameda, United States.